Clark Capital Management Group, Inc.
Position in GILD — Gilead Sciences, Inc.
CIK 1352187
PHILADELPHIA, PA
Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$50,003,224
+$49,769,919 QoQ
Shares Held
395,783
+23543.0% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#211
of 2,266 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clark Capital Management Group, Inc. holds $673,709,624 across 9 Drug Manufacturers - General names. GILD ranks #5 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
980,465 | $249,008,696 | |
| 2 | LLY |
ELI LILLY & Co
|
141,416 | $169,618,607 | |
| 3 | AZN |
Astrazeneca PLC
|
608,068 | $115,301,854 | |
| 4 | MRK |
Merck & Co., Inc.
|
652,471 | $83,842,523 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
395,783 | $50,003,224 | |
| 6 | ABBV |
AbbVie Inc.
|
10,043 | $2,527,220 | |
| 7 | NVS |
Novartis AG
|
14,258 | $2,234,513 | |
| 8 | AMGN |
Amgen Inc
|
1,626 | $588,807 |
All Filings in GILD
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,003,224 | 395,783 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $233,305 | 1,674 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||